Iranian nuclear scientists have developed a radiopharmaceutical named Florbetapir, capable of detecting Alzheimer's disease up to 20 years before symptoms appear. This breakthrough, achieved after two years of research despite international sanctions, allows for early diagnosis and potential treatment strategies to slow the disease's progression. A case study showed positive outcomes in a patient with cognitive impairment, highlighting the significance of early detection. To date, 80 patients have been treated with Florbetapir, with medical specialists reporting impressive results in identifying Alzheimer's early.
Tue, 29 Jul 2025 18:39:00 GMT | PressTV